Phase II study of decitabine in acute myeloid leukemia
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 May 2016 Time frame for primary endpoint has been changed.
- 18 May 2016 Status changed from active, no longer recruiting to completed.